NASDAQ:MCRB - Seres Therapeutics, Inc.
$6.20
 $0.35
+5.98%
2:00PM EDT
2019-02-15
Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens. The Company is also conducting research on metabolic diseases, such as early-stage, non-insulin dependent diabetes; non-alcoholic steatohepatitis, and obesity and metabolic syndrome.As of December 31, 2016, the Company's SER-109, a bacterial spore ecology, consisted of an average of approximately 50 bacterial species derived from healthy donors' fecal matter. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MCRB     avg for
industry  
  avg for
sector  
42 stocks weight:  30. 51   0. 00   0. 00  
42 stocks rank:  3. 31 K 1. 86 K 1. 09 K
# analyst opinions:  5. 00   14. 92   14. 43  
mean recommendation:  1. 80   1. 91   1. 93  

quick ratio:  1. 87   5. 37   1. 81  
current ratio:  2. 04   5. 69   2. 19  

target price low:  6. 37   88. 97   117. 82  
target price avg:  7. 00   115. 19   141. 96  
target price high:  14. 60   143. 40   163. 16  
1-yr high:  10. 08   124. 30   142. 77  
last close:  5. 85   101. 85   127. 84  
50-day avg:  6. 01   98. 27   122. 46  
200-day avg:  7. 48   99. 72   122. 70  
1-yr low:  4. 52   78. 19   100. 16  
volume:  65. 48 K 2. 38 M 4. 64 M
50-day avg volume:  105. 63 K 3. 31 M 4. 94 M
200-day avg volume:  119. 99 K 3. 23 M 4. 28 M

1-day return:  -2. 34 % 0. 22 % 0. 48 %
this week return:  -2. 34 % 1. 77 % 2. 01 %
12-wk return:  -27. 06 % 6. 56 % 3. 33 %
52-wk return:  -30. 76 % -2. 23 % 14. 35 %

enterprise value (EV):  172. 65 M 55. 17 B 104. 51 B
market cap:  239. 79 M 49. 01 B 96. 46 B
EBITDA:  -100. 62 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 72   -91. 79   2. 29  
enterprise/revenue (EV/R):  8. 34   29. 84   23. 39  
total revenue:  20. 69 M 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -106. 61 M 2. 37 B 3. 58 B

shares outstanding:  40. 86 M 607. 99 M 1. 22 B
shares:  20. 78 M 605. 53 M 1. 15 B
shares short:  3. 95 M 11. 62 M 12. 55 M
shares short prior month:  3. 83 M 11. 95 M 13. 44 M
short ratio:  36. 06   4. 82   3. 10  
short % of float:  27. 55 % 6. 19 % 2. 82 %
total cash/share:  1. 78   12. 02   11. 46  
total cash:  72. 89 M 7. 41 B 7. 37 B
free cash flow:  -34. 92 M 95. 99 M 2. 04 B
operating cash flow:  -96. 13 M 164. 74 M 3. 04 B

book value:  -0. 75   14. 43   28. 26  
price/book:  -7. 82   -1. 57   -2. 97  
gross profits:  -57. 35 M 8. 28 B 18. 09 B
operating margins:  -523. 76 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  11. 09 % --- ---
1-yr mean volatility:  -0. 09 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 62   3. 03   4. 09  
forward EPS:  -1. 89   4. 33   6. 99  
P/E:  -2. 23   6. 11   26. 91  
forward P/E:  -3. 17   8. 38   10. 48  
PE/G:  0. 04   0. 37   5. 61  
growth:  -60. 70 % 683. 72 % 104. 79 %
earnings high:  0. 24   1. 27   1. 66  
earnings avg:  -0. 50   1. 01   1. 53  
earnings low:  -0. 78   0. 76   1. 40  
revenue high:  43. 00 M 2. 86 B 11. 19 B
revenue avg:  13. 10 M 2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -42. 22 % -3. 27 % 3. 81 %
return on equity:  -388. 04 % 107. 48 % 27. 82 %
revenue growth:  -60. 70 % 648. 36 % 97. 70 %
revenue/share:  0. 51   14. 68   59. 83  

beta (1yr vs S&P500):  1. 30   1. 21   0. 93  
sharpe (1yr):  -0. 39   0. 06   0. 98  

held % insiders:  17. 57 % 6. 46 % 3. 21 %
held % institutions:  78. 94 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : MCRB
.        + 0 =             0 :: INITIAL WEIGHT
.  + 309.962 =       309.962 :: inverse volume-to-price addition
.  + 419.595 =       729.557 :: spline projection addition
.  - 156.688 =       572.869 :: poor performance penalty
.    x 0.801 =       458.818 :: one-year gains+dividend factor
.    x 4.861 =      2230.471 :: 13 weeks' performance factor
.    x 1.492 =      3328.954 :: industry recommendation factor
.    x 2.389 =      7952.678 :: symbol recommendation factor
.     x 1.28 =     10176.478 :: EV/R factor
.    x 0.996 =     10133.516 :: return on assets factor
.    x 0.961 =      9740.296 :: return on equity factor
.    x 0.994 =      9681.173 :: revenue growth factor
.    x 2.358 =     22826.001 :: current ratio factor
.    x 1.439 =     32838.171 :: quick ratio factor
.    x 1.014 =     33290.384 :: short ratio factor
.    x 1.922 =     63977.175 :: price-to-book factor
.    x 2.163 =    138380.989 :: P/E weight
.    x 2.209 =    305677.946 :: PE/G factor
.    x 1.688 =    516065.214 :: beta factor
.    x 0.393 =    203035.473 :: sharpe factor
.    x 1.299 =     263752.23 :: target low factor
.    x 1.148 =    302732.592 :: target mean factor
.    x 1.122 =    339756.757 :: target high factor
.    x 1.066 =    362049.152 :: industry 12-weeks return
.    x 0.999 =    361820.383 :: overall "drift" factor
.    x 0.889 =    321692.429 :: largest single-day jump factor
.    x 0.088 =     28392.977 :: low price factor
.      x 1.0 =     28394.883 :: factor hist industry gain for week 06
.   cubeRoot =        30.508 :: reduced for readability
.                     30.508 :: FINAL WEIGHT for NASDAQ:MCRB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org